FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to new compounds of formula (I):
, wherein R represents H, R5C(O), R5CH2OC(O) or R5CH2NHC (O); R1 represents or wherein an intersecting dash line shows a bond formed by attaching R1 to a molecule of formula (I); R2 and R3 independently represent OH or provided R2 and R3 are not OH simultaneously; R4 represents H; R5 has a general formula: CH3-(CH2)n-(CH=CH-CH2)m-CH=CH-(CH2)k-; k represents an integer 0 to 7; m represents an integer 0 to 2; and n represents an integer 0 to 10, or their pharmaceutically acceptable salts thereof. These compounds possess anticancer activity.
EFFECT: invention refers to a pharmaceutical compositions of these compounds and to the use of them for preparing a drug for cancer diseases.
15 cl, 4 tbl, 11 ex, 1 dwg
Title | Year | Author | Number |
---|---|---|---|
DIOXOLANE DERIVATIVES FOR CANCER TREATMENT | 2006 |
|
RU2418795C2 |
AZACYTIDINE ANALOGUES AND USE THEREOF | 2008 |
|
RU2487883C2 |
COMPOUNDS FOR TREATING CANCER | 2015 |
|
RU2733393C2 |
COMPOUNDS FOR TREATMENT OF CANCER | 2015 |
|
RU2805949C2 |
COMPOUNDS FOR TREATING TRIPLE-NEGATIVE BREAST CANCER AND OVARIAN CANCER | 2019 |
|
RU2776897C2 |
NOVEL APPLICATION OF ARYL-QUINOLINE DERIVATIVES AS INHIBITORS OF VASCULOGENIC MIMICRY | 2016 |
|
RU2685731C1 |
METHODS OF TREATMENT | 2020 |
|
RU2822394C1 |
BENZO[b]THIOPHENE STING AGONISTS FOR TREATMENT OF CANCER | 2018 |
|
RU2771811C2 |
COMPOUNDS BOUND WITH BIR DOMAIN OF IAP | 2007 |
|
RU2446170C2 |
COMBINED THERAPY WITH TETRACYCLIC QUINOLONE ANALOGUES FOR CANCER TREATMENT | 2016 |
|
RU2752506C2 |
Authors
Dates
2013-07-27—Published
2008-09-25—Filed